Overview
- 98 inspections across 95 sites are on record.
- 306 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-29.
At a glance
Inspections
98
Sites
95
Observations
306
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Samson Pharmaceuticals, Inc | 29 Apr 2026 | Human Drugs | View 483 → |
| University Of Texas MD Anderson Cancer Center: PET | 24 Feb 2026 | Human Drugs | View 483 → |
| International Medication Systems Ltd. | 19 Dec 2025 | Human Drugs | View 483 → |
| Kindeva Drug Delivery L.P. | 13 Nov 2025 | Human Drugs | View 483 → |
| ProRx LLC | 19 Sep 2025 | Human Drugs | View 483 → |
Sites inspected
Samson Pharmaceuticals, IncCommerce, United States1 insp.
University Of Texas MD Anderson Cancer Center: PETHouston, United States1 insp.
International Medication Systems Ltd.South El Monte, United States1 insp.
Kindeva Drug Delivery L.P.Northridge, United States1 insp.
ProRx LLCExton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Uttaniti Limchumroon7 shared
Crystal Monroy3 shared
Suzanne N Vallez3 shared
Lori B Wikstrom3 shared
Alan L Truong3 shared
Greg K Keshishyan3 shared
Santos E Camara2 shared
Gam S Zamil2 shared
Marcellinus D Dordunoo2 shared
Phal K Chhun2 shared
Full investigator report
Get the verbatim findings behind Taichun Qin's 306 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site